Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-05T19:28:56.015Z Has data issue: false hasContentIssue false

X-ray powder diffraction data for nicotine 3,5-dihydroxybenzoate dihydrate, C10H15N2⋅C7H5O4⋅2H2O

Published online by Cambridge University Press:  25 January 2021

Ji Yang
Affiliation:
R&D Center of China Tobacco Yunnan Industrial Co., Ltd, Kunming650231, China
Zhi Hua Liu
Affiliation:
R&D Center of China Tobacco Yunnan Industrial Co., Ltd, Kunming650231, China
Rui Zhi Zhu
Affiliation:
R&D Center of China Tobacco Yunnan Industrial Co., Ltd, Kunming650231, China
Neng Jun Xiang
Affiliation:
R&D Center of China Tobacco Yunnan Industrial Co., Ltd, Kunming650231, China
Shi Yun Tang
Affiliation:
R&D Center of China Tobacco Yunnan Industrial Co., Ltd, Kunming650231, China
Pei He
Affiliation:
R&D Center of China Tobacco Yunnan Industrial Co., Ltd, Kunming650231, China
Zi Li Suo
Affiliation:
School of Chemical Engineering, Sichuan University, Chengdu610065, China
Hui Li*
Affiliation:
School of Chemical Engineering, Sichuan University, Chengdu610065, China
*
a)Author to whom correspondence should be addressed. Electronic mail: [email protected]

Abstract

Nicotine 3,5-dihydroxybenzoate dihydrate is a nicotine salt and can be used as compositions in tobacco products. X-ray powder diffraction data, unit-cell parameters, and space group for nicotine 3,5-dihydroxybenzoate, C10H15N2⋅C7H5O4⋅2H2O, are reported [a = 8.424(1) Å, b = 13.179(8) Å, c = 8.591(1) Å, α = 90°, β = 102.073(8)°, γ = 90°, unit-cell volume V = 932.765(3) Å3, Z = 2, ρcal = 1.256 g⋅cm−3, and space group P21] at room temperature. All measured lines were indexed and are consistent with the P21 space group.

Type
New Diffraction Data
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press on behalf of International Centre for Diffraction Data

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, S. S. and Cobb, R. (1967). “2 non-steroidal anti-inflammatory drugs,” Prog. Med. Chem. 5, 59138.CrossRefGoogle Scholar
Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., and Puschmann, H. (2009). “OLEX2: a complete structure solution, refinement and analysis program,” J. Appl. Crystallogr. 42, 339341.CrossRefGoogle Scholar
Dull, G. M., Car, A., and Sharp, E. (2015). “Nicotine salts, co-crytals, and salt co-crystal complexes,” Patent No.: WO2015183801A1.Google Scholar
Dull, G. M., Carr, A., and Sharp, E. (2017). “Nicotine salts, co-crytals, and salt co-crystal complexes,” Patent No.: US9738622B2.Google Scholar
Grant, O., Pritchard, J. D., Prue, C., Thompson, J., Verron, T., Graf, D., and Walele, T. (2019). “A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers,” Intern. Emerg. Med. 14, 853861.Google Scholar
Neumann, M. A. (2003). “X-Cell: a novel indexing algorithm for routine tasks and difficult cases,” J. Appl. Crytallogr. 36, 356365.CrossRefGoogle Scholar
Pawley, G. S. (1981). “Unit-cell refinement from powder diffraction scans,” J. Appl. Crystallogr. 14(6), 357361.CrossRefGoogle Scholar
Sheldrick, G. M. (2008). “Foundations of crystallography,” Acta Crystallogr. A 64, 112122.CrossRefGoogle Scholar
Sheldrick, G. M. (2015). “Crystal structure refinement with SHELXL,” Acta Cryst. C71, 38.Google Scholar
Supplementary material: File

Yang et al. supplementary material

Table S1

Download Yang et al. supplementary material(File)
File 39.4 KB